共有 50 笔近期内部人交易记录记录，涉及 ImageneBio Inc (IMA), 包括 38 笔买入 和 4 笔卖出. 内部人买入总额为 $3.75M 内部人卖出总额为 $140.77K.
近期活跃的重要内部人包括 Yarema Kristin, Porter-brown Benjamin, Butler Erin. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — IMA
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-16 |
Yarema Kristin |
Chief Executive Officer |
限制性股票授予 (RSU) |
85,400 |
- |
- |
85,400 |
| 2026-02-16 |
Porter-brown Benjamin |
Officer |
未知 |
- |
- |
- |
- |
| 2025-12-30 |
Butler Erin |
Principal Accounting Officer |
限制性股票授予 (RSU) |
22,500 |
$7.11 |
$159.98K |
22,500 |
| 2025-12-24 |
Slattery Joseph P |
Director |
知情买入 |
16,000 |
$5.99 |
$95.84K |
16,000 |
| 2025-12-18 |
Slattery Joseph P |
Director |
限制性股票授予 (RSU) |
31,200 |
$6.19 |
$193.13K |
31,200 |
| 2025-12-18 |
Wang Jonathan Jian |
Director |
限制性股票授予 (RSU) |
31,200 |
$6.19 |
$193.13K |
31,200 |
| 2025-12-18 |
Wang Stephen Hui |
Director |
限制性股票授予 (RSU) |
31,200 |
$6.19 |
$193.13K |
31,200 |
| 2025-11-01 |
Slattery Joseph P |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-28 |
Marango Jotin |
Chief Financial Officer |
RSU 预扣税 |
4,630 |
$17.16 |
$79.45K |
11,146 |
| 2025-07-28 |
Yarema Kristin |
Chief Executive Officer |
限制性股票授予 (RSU) |
153,505 |
- |
- |
153,505 |
| 2025-07-25 |
Lu Yufang |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-25 |
Lu Yufang |
Chief Medical Officer |
限制性股票授予 (RSU) |
4,591 |
$4.59 |
$21.07K |
4,591 |
| 2025-07-25 |
Wang Jonathan Jian |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-25 |
Wang Jonathan Jian |
Director |
限制性股票授予 (RSU) |
143,832 |
- |
- |
143,832 |
| 2025-07-25 |
Wang Stephen Hui |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-25 |
Wang Stephen Hui |
Director |
限制性股票授予 (RSU) |
12,535 |
- |
- |
12,535 |
| 2025-07-25 |
Marango Jotin |
Chief Financial Officer |
股份退回 |
397,199 |
- |
- |
- |
| 2025-07-25 |
Yarema Kristin |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-25 |
Butler Erin |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-25 |
Butler Erin |
Principal Accounting Officer |
限制性股票授予 (RSU) |
3,051 |
- |
- |
3,051 |
| 2025-07-25 |
Orbimed Advisors Llc |
Director |
限制性股票授予 (RSU) |
83,611 |
$2.49 |
$208.19K |
287,885 |
| 2025-07-25 |
Stampacchia Otello |
Director |
期权行权（卖出） |
17,520 |
$1.75 |
$30.66K |
- |
| 2025-07-25 |
Bonita David P |
Director |
期权行权（卖出） |
17,520 |
$1.75 |
$30.66K |
- |
| 2024-06-07 |
Formela Jean Francois |
Director |
限制性股票授予 (RSU) |
17,520 |
$1.75 |
$30.66K |
17,520 |
| 2024-06-07 |
Stampacchia Otello |
Director |
限制性股票授予 (RSU) |
17,520 |
$1.75 |
$30.66K |
17,520 |
| 2024-06-07 |
Bonita David P |
Director |
限制性股票授予 (RSU) |
17,520 |
$1.75 |
$30.66K |
17,520 |
| 2024-06-07 |
Hughes Owen |
Director |
限制性股票授予 (RSU) |
17,520 |
$1.75 |
$30.66K |
17,520 |
| 2024-06-07 |
Dukes Iain D. |
Director |
限制性股票授予 (RSU) |
17,520 |
$1.75 |
$30.66K |
17,520 |
| 2024-06-07 |
Wooster Richard |
Director |
限制性股票授予 (RSU) |
17,520 |
$1.75 |
$30.66K |
17,520 |
| 2024-06-07 |
Koehler Maria |
Director |
限制性股票授予 (RSU) |
17,520 |
$1.75 |
$30.66K |
17,520 |
| 2024-03-01 |
Germa Caroline |
Chief Medical Officer |
限制性股票授予 (RSU) |
579,100 |
$1.47 |
$851.28K |
579,100 |
| 2024-02-29 |
Germa Caroline |
Officer |
未知 |
- |
- |
- |
- |
| 2024-02-01 |
Marango Jotin |
CFO & Head of Corp. Dev. |
限制性股票授予 (RSU) |
181,000 |
$1.36 |
$246.16K |
181,000 |
| 2024-02-01 |
Ecsedy Jeffrey |
Chief Development Officer |
限制性股票授予 (RSU) |
100,000 |
$1.36 |
$136K |
100,000 |
| 2024-02-01 |
Manfredi Mark |
President & CEO |
限制性股票授予 (RSU) |
320,000 |
$1.36 |
$435.2K |
320,000 |
| 2023-08-04 |
Orbimed Advisors Llc |
Director |
限制性股票授予 (RSU) |
353,192 |
- |
- |
353,192 |
| 2023-08-04 |
Bonita David P |
Director |
限制性股票授予 (RSU) |
353,192 |
- |
- |
353,192 |
| 2023-08-04 |
Orbimed Advisors Llc |
Director |
限制性股票授予 (RSU) |
353,192 |
- |
- |
353,192 |
| 2023-08-04 |
Bonita David P |
Director |
限制性股票授予 (RSU) |
353,192 |
- |
- |
353,192 |
| 2023-06-09 |
Formela Jean Francois |
Director |
限制性股票授予 (RSU) |
17,520 |
$6.51 |
$114.06K |
17,520 |
| 2023-06-09 |
Stampacchia Otello |
Director |
限制性股票授予 (RSU) |
17,520 |
$6.51 |
$114.06K |
17,520 |
| 2023-06-09 |
Bonita David P |
Director |
限制性股票授予 (RSU) |
17,520 |
$6.51 |
$114.06K |
17,520 |
| 2023-06-09 |
Hughes Owen |
Director |
限制性股票授予 (RSU) |
17,520 |
$6.51 |
$114.06K |
17,520 |
| 2023-06-09 |
Dukes Iain D. |
Director |
限制性股票授予 (RSU) |
17,520 |
$6.51 |
$114.06K |
17,520 |
| 2023-06-09 |
Wooster Richard |
Director |
限制性股票授予 (RSU) |
17,520 |
$6.51 |
$114.06K |
17,520 |
| 2023-06-09 |
Koehler Maria |
Director |
限制性股票授予 (RSU) |
17,520 |
$6.51 |
$114.06K |
17,520 |
| 2023-01-03 |
Santillana Sergio L. |
Chief Medical Officer |
限制性股票授予 (RSU) |
105,000 |
- |
- |
105,000 |
| 2023-01-03 |
Marango Jotin |
CFO & Head of Corp. Dev. |
限制性股票授予 (RSU) |
105,000 |
- |
- |
105,000 |
| 2023-01-03 |
Ecsedy Jeffrey |
Chief Development Officer |
限制性股票授予 (RSU) |
105,000 |
- |
- |
105,000 |
| 2023-01-03 |
Manfredi Mark |
President & CEO |
限制性股票授予 (RSU) |
220,000 |
- |
- |
220,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
